AzTrials
AzTrials

Anterior Cruciate Ligament ReconstructionNCT04079205

Home Rehabilitation Using Smart Wearable Exercise and Electrical Stimulation Device After Anterior Cruciate Ligament Reconstruction

A study testing Wearable Device(exoRehab) and Home rehabilitation program in people with Anterior Cruciate Ligament Reconstruction, run by Seoul National University Bundang Hospital at 1 site in South Korea.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to develop and apply a rehabilitation program for patients who are discharged after ACL reconstruction using a wearable joint rehabilitation exercise device (exoRehab). Read more about this study

Who is it for?
Ages 19 years and older
What is being tested?
Wearable Device(exoRehab) and Home rehabilitation program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteSouth Korea
Study dates
31 Dec 2018to 30 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with anterior cruciate ligament reconstruction
  • Patients who are older than 19 years of age

Who cannot join

  • History of surgery or traumatic injury to the uninvolved lower extremity
  • Complication after ACL reconstruction surgery
  • Dermatological conditions affecting the thigh
  • Body mass index (BMI) greater than 40 kg/m2
  • Implanted pacemakers or defibrillators
  • Significant neurologic impairments
Show all 10Show fewer
  • Other unstable lower-extremity orthopedic conditions
  • Initiated rehabilitation at another facility prior to their first physical therapy session at our facility
  • Other lower limb impairment affecting function
  • More than one surgery for a tear of the ACL

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 463-707

Other trials in South Korea

About this study

Official title: Home-based Rehabilitation Using Smart Wearable Knee Exercise Device With Electrical Stimulation After Anterior Cruciate Ligament Reconstruction: A Study Protocol for a Randomized Controlled Trial

The purpose of this study is to develop and apply a rehabilitation program for patients who are discharged after ACL reconstruction using a wearable joint rehabilitation exercise device (exoRehab).

Read the detailed description

This randomized, single-blind, controlled trial included 40 patients who are discharged after ACL reconstruction.

The intervention group(n=20) was instructed and educated about 6 week home rehabilitation program using a wearable device(exoRehab)

The controls(n=20) was instructed and educated about 6 week conventional home rehabilitation program

Two weeks after surgery and six weeks after discharge, evaluation is performed.

The purpose of this study is to develop and apply a rehabilitation program for patients who are discharged after ACL reconstruction using a wearable joint rehabilitation exercise device (exoRehab).

Being tested
Wearable Device(exoRehab), Home rehabilitation program
Keywords
Anterior Cruciate Ligament Reconstruction, Wearable device, Knee, Neuromuscular Electrical Stimulation, Exercise
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Wearable Device(exoRehab)Device

    rehabilitation program for patients after Anterior Cruciate Ligament Reconstruction using Wearable Device (exoRehab)

  • Home rehabilitation programBehavioural

    rehabilitation program for patients after Anterior Cruciate Ligament Reconstruction

Study groups in NCT04079205
Study groupRoleWhat they receive
Home rehabilitation using Wearable DeviceExperimentalHome rehabilitation using Wearable Device(exoRehab)
Receives: Device: Wearable Device(exoRehab)
ControlActive comparatorStandard home rehabilitation program
Receives: Behavioral: Home rehabilitation program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quadriceps muscle strength using dynamometry

    Change from baseline quadriceps muscle strength at 6 weeks

    Measured: Baseline and 6 weeks

Secondary outcomes (8)
  1. Active range of motion of knee

    Change from baseline active range of motion of knee at 2 weeks and 6 weeks

    Measured: Baseline, 2 weeks and 6 weeks

  2. Passive range of motion of knee

    Change from baseline passive range of motion of knee at 2 and 6 weeks

    Measured: Baseline, 2 weeks and 6 weeks

  3. Root mean square of surface electromyography of quadriceps muscle

    Change from baseline root mean square of surface electromyography of quadriceps muscle at 2 weeks and 6 weeks

    Measured: Baseline, 2 weeks and 6 weeks

  4. International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Score

    Changes from baseline in International Knee Documentation Committee (IKDC) subjective score at 2 weeks and 6 weeks, Higher scores indicate better recovery

    Measured: Baseline, 2 weeks and 6 weeks

  5. Lysholm score

    Change from baseline in Lysholm score at 2 weeks and 6 weeks. Lysholm score ranges from 0-100 with higher scores indicating better knee joint function.

    Measured: Baseline, 2 weeks and 6 weeks

  6. Knee Outcome Survey-Activities of Daily Living Scale

    Change from baseline in score of Knee Outcome Survey-Activities of Daily Living Scale at 2 weeks and 6 weeks. Score ranges from 0-100 with higher scores indicating better knee joint function.

    Measured: Baseline, 2 weeks and 6 weeks

  7. EQ-5D-3L Scores

    Change from baseline in EQ-5D-3L Scores at 2 weeks and 6 weeks. EQ-5D-3L is made up for two components. First, the health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression; each dimension ranging from 1-3. From these five dimensions, EQ-5D index is calculated, having a value between 0-1. Second, the evaluation part involves an analogue scale, asking to mark health status on the day of the interview on a 20 cm vertical scale with end points of 0 and 100. Zero corresponds to " the worst health you can imagine", and hundred corresponds to "the best health you can imagine".

    Measured: Baseline, 2 weeks and 6 weeks

  8. Visual Analogue Scale for pain

    Change from baseline in Visual Analogue Scale at 2 weeks and 6 weeks. The Visual Analogue Scale(VAS), a 101-point scale for evaluating pain which consists of a 100-millimetre scale ranging from 0 (no pain at all) to 100 (worst imaginable pain).

    Measured: Baseline, 2 weeks and 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Sep 2019
  2. Study start31 Dec 2018
  3. Primary completion30 Jun 2021
  4. Study completion30 Jun 2021

Why it stopped: Due to difficulty in patient enrollment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04079205
Sponsor's protocol ID
B-1806-475-006
Status last verified
Sep 2021
First submitted
8 May 2019
Last updated
27 Sep 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Kim G, Kim WS, Kim TW, Lee YS, Lee H, Paik NJ. Home-based rehabilitation using smart wearable knee exercise device with electrical stimulation after anterior cruciate ligament reconstruction: A study protocol for a randomized controlled trial. Medicine (Baltimore). 2020 May;99(20):e20256. doi: 10.1097/MD.0000000000020256.

    PubMed 32443364

Questions about this trial

What is this clinical trial studying?

A study testing Wearable Device(exoRehab) and Home rehabilitation program in people with Anterior Cruciate Ligament Reconstruction, run by Seoul National University Bundang Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 27 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Due to difficulty in patient enrollment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quadriceps muscle strength using dynamometry (time frame: Baseline and 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04079205, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2021; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in